Ratification Date: 25/07/2025

Next Review Date: 25/07/2027

Goserelin – Prostate cancer

Drug Name (Brand) Goserelin  (Zoladex®)
Indication Prostate cancer
Traffic Light Classification Advice
NICE TA (plus link)  
Further Information:

NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.

 

Consultant initiation only.

November 2010: View confirmed by the TAG.

 

July 2018:

Reaffirmed by the TAG and the D&TC.

 

Date of TAG recommendation / ratification 1/1/1996 Review Date